These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 765561)

  • 1. [Virulence of BCG and induction of cellular immunity (2)].
    Miura K; Takahashi H; Murohashi T; Hashimoto T
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):255. PubMed ID: 765561
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
    Dannenberg AM
    Tuberculosis (Edinb); 2001; 81(1-2):87-96. PubMed ID: 11463228
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivity of the protection test in guinea pigs vaccinated by BCG. I. Influence of age or slight viability margins of BCG cultures].
    Frappier A; Portelance V; Marois P; St-Pierre J
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):425-47. PubMed ID: 4860409
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of the immune response by BCG: a review.
    Murahata RI; Mitchell MS
    Yale J Biol Med; 1976 Jul; 49(3):283-91. PubMed ID: 785826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"].
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of the study of the W 115 M. tuberculosis vaccine strain and the lyophilized experimental vaccine W 115.
    Weiszfeiler JG
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):492-7. PubMed ID: 812909
    [No Abstract]   [Full Text] [Related]  

  • 7. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute BCG-infection].
    Muftic M
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 135(5):370-6. PubMed ID: 4876570
    [No Abstract]   [Full Text] [Related]  

  • 9. [BCG: symposium].
    Takase Y; Kayaba K; Kobayashi T; Horai Z; Yokoi M
    Kekkaku; 1970 Nov; 45(11):390-2. PubMed ID: 4924414
    [No Abstract]   [Full Text] [Related]  

  • 10. An experimental model for immunotherapy of cancer.
    Zbar B; Ribi E; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.
    Dannenberg AM; Collins FM
    Tuberculosis (Edinb); 2001; 81(3):229-42. PubMed ID: 11466035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A technique for intensifying BCG sensitivity.
    Parmett SR; Klein E
    J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Residual virulence of lyophilized commercial BCG-Brazil vaccine, and of the one cultured in Dubos media for mice].
    Fonseca Lde S; Gontijo Filho PP
    An Microbiol (Rio J); 1979; 24():182-9. PubMed ID: 400665
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypersensitivity of the delayed type and formation of immunity during the infectious process].
    Berezhnaia NM
    Usp Sovrem Biol; 1978; 85(1):85-97. PubMed ID: 349917
    [No Abstract]   [Full Text] [Related]  

  • 18. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):436-43. PubMed ID: 812905
    [No Abstract]   [Full Text] [Related]  

  • 19. [BCG: substrains, the vaccine, vaccination].
    Balazs ED
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(3):117-24. PubMed ID: 9417279
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.